Literature DB >> 16402273

Gastrointestinal stromal tumours: a regular origin in the muscularis propria, but an extremely diverse gross presentation. A review of 200 cases to critically re-evaluate the concept of so-called extra-gastrointestinal stromal tumours.

Abbas Agaimy1, Peter H Wünsch.   

Abstract

BACKGROUND: Gastrointestinal stromal tumours (GISTs) are thought to arise from the interstitial cells of Cajal (ICCs). ICCs form a network surrounding the myenteric plexus and between-muscle fibres of the muscularis propria of the tubular GI tract. The cell of origin of so-called extra-gastrointestinal stromal tumours (EGISTs) is not known. AIM AND METHODS: To study the diversity of gross presentation of GISTs and to critically assess the incidence of EGISTs and their relationship to mural GISTs, a total of 200 neoplasms with typical morphologic and immunohistochemical features of GISTs were reviewed, looking for any degree of association with the muscularis propria of the gut wall.
RESULTS: There were 130 gastric (65%), 9 duodenal (4.5%), 48 small intestinal (24%), 9 colorectal (4.5%), 1 appendiceal (0.5%) and 3 unclassifiable GISTs (1.5%). Fourteen cases (7%) were initially submitted as EGISTs (four mesenteric, four omental, one pararectal/prostatic, one pelvic/Douglas, one perivesical, one located between root of mesentery and tail of pancreas, one involving the mesentery, omentum and abdominal wall extensively and one located between liver and stomach). After critical re-evaluation of surgical reports and remote clinical history and a careful search for residual muscular tissue from the gut wall in the tumour pseudocapsule (in some cases supported by desmin immunoreactivity), it was possible to reclassify most of these cases (11/14) as either GISTs with extensive extramural growth resulting in loss of contact to the external muscle coat of the gut (8/14) or as metastases from an inoperable GIST (2/14) or from a previously resected deceptively benign tumour (1/14).
CONCLUSION: EGISTs are probably rarer than previously reported (1.5% or less in this study). We concluded that most so-called EGISTs represent apparent EGISTs that should have arisen from the outermost muscle coat, but have lost their contact to the point of origin due to extensive extramural growth pattern. From a surgical point of view, it is crucial to document and mark any focal attachment or adhesions to the gut wall noticed during surgery for an apparent EGIST. In contrast to most other neoplasms, GISTs should be defined by virtue of any degree of association with the muscularis propria (no matter how minimal), but not by localisation of the bulk of the tumour.

Entities:  

Mesh:

Year:  2006        PMID: 16402273     DOI: 10.1007/s00423-005-0005-5

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  44 in total

1.  Cause of familial and multiple gastrointestinal autonomic nerve tumors with hyperplasia of interstitial cells of Cajal is germline mutation of the c-kit gene.

Authors:  S Hirota; T Okazaki; Y Kitamura; P O'Brien; L Kapusta; I Dardick
Journal:  Am J Surg Pathol       Date:  2000-02       Impact factor: 6.394

2.  Interstitial cells of Cajal in human small intestine. Ultrastructural identification and organization between the main smooth muscle layers.

Authors:  J J Rumessen; L Thuneberg
Journal:  Gastroenterology       Date:  1991-05       Impact factor: 22.682

3.  Gastrointestinal stromal tumor workshop.

Authors:  J Berman; T J O'Leary
Journal:  Hum Pathol       Date:  2001-06       Impact factor: 3.466

4.  [A case of gastrointestinal stromal tumor of rectum, difficult to differentiate from leiomyosarcoma of prostate].

Authors:  H Kuruma; T Ao; K Suyama; N Okuno; H Mizoguchi; M Murayama; K Koshiba; T Motoori
Journal:  Nihon Hinyokika Gakkai Zasshi       Date:  2001-09

Review 5.  Gastrointestinal stromal tumors--definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis.

Authors:  M Miettinen; J Lasota
Journal:  Virchows Arch       Date:  2001-01       Impact factor: 4.064

6.  [Gastrointestinal stromal tumor of the abdominal wall. An unusual localization of a rare tumor].

Authors:  A Thalheimer; D Meyer; S Gattenlöhner; W Timmermann; A Thiede
Journal:  Chirurg       Date:  2004-07       Impact factor: 0.955

7.  Stromal tumor of the pancreas with expression of c-kit protein: report of a case.

Authors:  Kazuhiro Yamaura; Kunitaka Kato; Masahisa Miyazawa; Yoshiaki Haba; Akira Muramatsu; Kazuyuki Miyata; Naohiko Koide
Journal:  J Gastroenterol Hepatol       Date:  2004-04       Impact factor: 4.029

8.  Pedunculated giant gastrointestinal stromal tumor of the stomach showing extragastric growth: report of a case.

Authors:  Hironobu Kimura; Toru Yoshida; Seiichi Kinoshita; Ichiro Takahashi
Journal:  Surg Today       Date:  2004       Impact factor: 2.549

9.  [Gastrointestinal stromal tumors: a broad clinical spectrum from incidental -discovery to acute gastrointestinal bleeding].

Authors:  E Siewert; L Tietze; C Maintz; A Geier; C G Dietrich; S Matern; C Gartung
Journal:  Z Gastroenterol       Date:  2004-03       Impact factor: 2.000

Review 10.  Malignant gastrointestinal stromal tumor of the gallbladder.

Authors:  Jong Kyung Park; Seung Hye Choi; Seong Lee; Ki Ouk Min; Sang Seob Yun; Hae Myung Jeon
Journal:  J Korean Med Sci       Date:  2004-10       Impact factor: 2.153

View more
  55 in total

1.  Gene mutations and prognostic factors analysis in extragastrointestinal stromal tumor of a Chinese three-center study.

Authors:  Song Zheng; Ke-er Huang; De-you Tao; Yue-long Pan
Journal:  J Gastrointest Surg       Date:  2011-01-28       Impact factor: 3.452

Review 2.  Histopathology of gastrointestinal stromal tumor.

Authors:  Markku Miettinen; Jerzy Lasota
Journal:  J Surg Oncol       Date:  2011-12       Impact factor: 3.454

3.  Primary GIST of the liver masquerading as primary intra-abdominal tumour: a rare extra-gastrointestinal stromal tumour (EGIST) of the liver.

Authors:  A Robert Louis; Shivendra Singh; Sunil K Gupta; Anila Sharma
Journal:  J Gastrointest Cancer       Date:  2014-09

4.  Pancreatic Malignant Gastrointestinal Stromal Tumor: a Case Report.

Authors:  Narendra Pandit; Tek Narayan Yadav; Robal Lacoul; Rajman Dongol; Laligen Awale; Shailesh Adhikary
Journal:  J Gastrointest Cancer       Date:  2020-03

5.  A single-institution experience with eight CD117-positive primary extragastrointestinal stromal tumors: critical appraisal and a comparison with their gastrointestinal counterparts.

Authors:  Brian K P Goh; Pierce K H Chow; Sittampalam M Kesavan; Wai-Ming Yap; Yaw-Fui A Chung; Wai-Keong Wong
Journal:  J Gastrointest Surg       Date:  2009-02-24       Impact factor: 3.452

6.  Extragastrointestinal stromal tumour of the abdominal wall - a case report.

Authors:  A Sathish Selva Kumar; R Padmini; G Veena; N Murugesan
Journal:  J Clin Diagn Res       Date:  2013-12-15

Review 7.  Malignant appendiceal GIST: case report and review of the literature.

Authors:  Ram Elazary; Avraham Schlager; Abed Khalaileh; Liat Appelbaum; Miklosh Bala; Mahmoud Abu-Gazala; Areej Khatib; Tzahi Neuman; Avraham I Rivkind; Gidon Almogy
Journal:  J Gastrointest Cancer       Date:  2010-03

8.  Depletion of telomerase RNA inhibits growth of gastrointestinal tumors transplanted in mice.

Authors:  Xue-Cheng Sun; Jing-Yi Yan; Xiao-Lei Chen; Ying-Peng Huang; Xian Shen; Xiao-Hua Ye
Journal:  World J Gastroenterol       Date:  2013-04-21       Impact factor: 5.742

9.  Long segmental hyperplasia of interstitial cells of Cajal with giant diverticulum formation.

Authors:  Liyan Xue; Tian Qiu; Ying Song; Ling Shan; Xiuyun Liu; Lei Guo; Jianming Ying; Shuangmei Zou; Susheng Shi; Alexandros D Polydorides; Xinming Zhao; Ning Lu; Dongmei Lin
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

Review 10.  [Gastrointestinal stromal tumors: evolution of a tumor concept from unclassifiable neoplasms to targeted molecular therapy].

Authors:  A Agaimy; R Schneider-Stock
Journal:  Pathologe       Date:  2010-03       Impact factor: 1.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.